Drugs / TIL infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02379195 | Nov 2014 → Jan 2018 | metastatic melanoma | Inge Marie Svane | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02379195 ↗ |
| Modality | Cell therapy | “Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs)” PMID 32747469 ↗ Jul 2020 |